Browsing by Author "Vidal, Enrico (57200885825)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication European chronic kidney disease registries for children not on kidney replacement therapy: tools for improving health systems and patient-centred outcomes(2023) ;Bakkaloglu, Sevcan A. (57542125800) ;Vidal, Enrico (57200885825) ;Bonthuis, Marjolein (36130877600) ;Neto, Gisela (57211564695) ;Paripović, Dušan (14621764400) ;Åsberg, Anders (7005233234) ;Hijosa, Marta Melgosa (57212935350) ;Vondrak, Karel (6603032157) ;Jankauskiene, Augustina (6603408774) ;Roussinov, Dimitar (14007781200) ;Awan, Atif (7005794049)Jager, Kitty J. (55382765700)Chronic kidney disease (CKD) in children, from birth to late adolescence, is a unique and highly challenging condition that requires epidemiological research and large-scale, prospective cohort studies. Since its first launch in 2007, the European Society for Paediatric Nephrology/European Renal Association (ESPN/ERA) Registry has collected data on patients on kidney replacement therapy (KRT). However, slowing the progression of CKD is of particular importance and thus the possibility to extend the current registry dataset to include patients in CKD stages 4–5 should be a priority. A survey was sent to the national representatives within the ESPN/ERA Registry to collect information on whether they are running CKD registries. All the representatives from the 38 European countries involved in the ESPN/ERA Registry participated in the survey. Eight existing CKD registries have been identified. General characteristics of the national registry and detailed data on anthropometry, laboratory tests and medications at baseline and at follow-up were collected. Results provided by this survey are highly promising regarding the establishment of an ESPN CKD registry linked to the ESPN/ERA KRT registry and subsequently linking it to the ERA Registry with the same patient identifier, which would allow us to monitor disease progression in childhood and beyond. It is our belief that through such linkages, gaps in patient follow-up will be eliminated and patient-centred outcomes may be improved. © The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. - Some of the metrics are blocked by yourconsent settings
Publication Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study(2025) ;Ortiz, Alberto (7201911399) ;Kramer, Anneke (35248676700) ;Ariceta, Gema (6602702810) ;Rodríguez Arévalo, Olga L. (58965537700) ;Gjerstad, Ann C. (57193450758) ;Santiuste, Carmen (57208944637) ;Trujillo-Alemán, Sara (56044688200) ;Ferraro, Pietro Manuel (25724310200) ;Methven, Shona (33067973200) ;Santamaría, Rafael (7006589626) ;Naumovic, Radomir (55965061800) ;Resic, Halima (6603023405) ;Hommel, Kristine (15826372800) ;Segelmark, Mårten (6701867637) ;Ambühl, Patrice M. (7003390294) ;Sorensen, Søren S. (7201971552) ;Parmentier, Cyrielle (56814526900) ;Vidal, Enrico (57200885825) ;Bakkaloglu, Sevcan A. (6701364048) ;Plumb, Lucy (56009867700) ;Palsson, Runolfur (6601953759) ;Kerschbaum, Julia (36876157200) ;ten Dam, Marc A. G J. (6602143496) ;Stel, Vianda S. (15728366500) ;Jager, Kitty J. (55382765700)Torra, Roser (7005575534)Background. Inherited kidney diseases (IKDs) and congenital anomalies of the kidney and urinary tract (CAKUT) are causes of kidney failure requiring kidney replacement therapy (KRT) that major renal registries usually amalgamate into the primary renal disease(PRD) category ‘miscellaneous’ or in the glomerulonephritis or pyelonephritis categories. This makes IKDs invisible (except for polycystic kidney disease) and may negatively influence the use of genetic testing, which may identify a cause for IKDs and some CAKUT. Methods. We re-examined the aetiology of KRT by composing a separate IKD and CAKUT PRD group using data from the European Renal Association (ERA) Registry. Results. In 2019, IKD-CAKUT was the fourth most common cause of kidney failure among incident KRT patients, accounting for 8.9% of cases [IKD 7.4% (including 5.0% autosomal dominant polycystic kidney disease), CAKUT 1.5%], behind diabetes (23.0%), hypertension (14.4%) and glomerulonephritis (10.6%). IKD-CAKUT was the most common cause of kidney failure among patients <20 years of age (41.0% of cases), but their incidence rate was highest among those ages 45–74 years (22.5 per million age-related population). Among prevalent KRT patients, IKD-CAKUT (18.5%) and glomerulonephritis (18.7%) were the two most common causes of kidney failure overall, while IKD-CAKUT was the most common cause in women (21.6%) and in patients <45 years of age (29.1%). Conclusion. IKD and CAKUT are common causes of kidney failure among KRT patients. Distinct categorization of IKD and CAKUT better characterizes the epidemiology of the causes of chronic kidney disease (CKD) and highlights the importance of genetic testing in the diagnostic workup of CKD. © The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.